Over 90 percent of subjects treated with the combination therapy experienced a ≥50 percent reduction in seizure frequency at six-months.
Six of the seven participants reported “an improvement in symptoms” and “none of the participants reported any adverse side effects.”
“The findings of this study indicate that neither past nor current cannabis use are associated with the likelihood of having clinical hypertension,” investigators concluded.
One-in-four respondents reported reducing their need for medical interventions since using cannabis, and nearly one-third acknowledged reducing their use of prescription medications.
“[T]he impacts of recreational cannabis legalization on psychiatric and psychosocial outcomes are otherwise minimal,” researchers concluded.
The use of cannabis products was associated with “statistically significant improvements in IBD-specific outcomes” at three months.
Compared to those residing in legal states, residents in states were marijuana was illegal “reported a significantly greater number of days driving under the influence of cannabis.”
Investigators concluded, “All patient-reported outcomes showed a statistically significant improvement at 3 months, which was maintained or further improved over the remainder of the 12-month follow-up.”